Journal of Clinical Oncology, Vol 15, 2205-2213, Copyright © 1997 by American Society of Clinical Oncology

ARTICLES

Late mortality of long-term survivors of childhood cancer

MM Hudson, D Jones, J Boyett, GB Sharp and CH Pui
Department of Hematology-Oncology, St Jude Children's Research Hospital, The University of Tennessee, Memphis, College of Medicine 38105, USA. melissa.hudson@stjude.org

PURPOSE: To determine the frequency and patterns of late mortality among long-term survivors of childhood cancer. MATERIALS AND METHODS: Medical records of patients who survived at least 5 years after the diagnosis of childhood cancer were reviewed to determine the causes of subsequent deaths. Estimated 15-year survival and standardized mortality ratios for deaths from nonneoplastic treatment complications were compared with adjusted United States population estimates. The study included 2,053 patients who had survived > or = 5 years, grouped by treatment eras that reflected increased intensity of therapy and significantly improved survival (early era, 1962 to 1970; recent era, 1971 to 1983). RESULTS: There have been 258 subsequent deaths in the 2,053 childhood cancer survivors; 169 occurred 5 to 10 years postdiagnosis and 89 > or = 10 years post diagnosis. For the study period as a whole, deaths were attributed to recurrent primary malignancy in 61% of cases, second malignancy in 20%, nonneoplastic treatment complication in 10%, and unintentional injury/suicide in 8%. Late death from recurrent disease decreased significantly for survivors treated in the recent era (P < .0001), while the risk of death from second malignancies increased, although not statistically significantly (P = .10). Projected 15-year survival estimates for all > or = 5-year survivors in both treatment eras was greater than 90%, but differed from expected rates. CONCLUSION: Late mortality from recurrence after treatment for childhood cancer decreases with more effective initial therapy. Prolonged disease-free status is associated with an expected survival that approaches that of the general population for patients treated from 1971 through 1983. The impact of more recent intensified and novel therapies for high-risk patients remains to be determined.

This article has been cited by other articles:

				R. Mody, S. Li, D. C. Dover, S. Sallan, W. Leisenring, K. C. Oeffinger, Y. Yasui, L. L. Robison, and J. P. Neglia Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study Blood, June 15, 2008; 111(12): 5515 - 5523. [Abstract] [Full Text] [PDF]

				E. C. van Dalen and L. C. M. Kremer Effect of Dosing Schedules on Anthracycline-induced Cardiotoxicity in Children with Cancer ASCO Educational Book, January 1, 2008; 2008(1): 442 - 447. [Abstract] [Full Text] [PDF]

				E Steliarova-Foucher, V Arndt, D. Parkin, F Berrino, and H Brenner Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System Ann. Onc., September 1, 2007; 18(9): 1554 - 1560. [Abstract] [Full Text] [PDF]

				R. A. Howard, P. D. Inskip, and L. B. Travis Suicide After Childhood Cancer J. Clin. Oncol., February 20, 2007; 25(6): 731 - 731. [Full Text] [PDF]

				C. J. Recklitis, M. A. Rothwell, L. R. Diller, and R. A. Lockwood In Reply J. Clin. Oncol., February 20, 2007; 25(6): 733 - 734. [Full Text] [PDF]

				M. M. Hawkins, A. C. Mertens, T. R. Moller, and S. Garwicz Suicide Among Survivors of Childhood Cancer J. Clin. Oncol., February 20, 2007; 25(6): 731 - 732. [Full Text] [PDF]

				M. Bassal, A. C. Mertens, L. Taylor, J. P. Neglia, B. S. Greffe, S. Hammond, C. M. Ronckers, D. L. Friedman, M. Stovall, Y. Y. Yasui, et al. Risk of Selected Subsequent Carcinomas in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study J. Clin. Oncol., January 20, 2006; 24(3): 476 - 483. [Abstract] [Full Text] [PDF]

				S. Shankar, L. Robison, M. E.M. Jenney, T. H. Rockwood, E. Wu, J. Feusner, D. Friedman, R. L. Kane, and S. Bhatia Health-Related Quality of Life in Young Survivors of Childhood Cancer Using the Minneapolis-Manchester Quality of Life-Youth Form Pediatrics, February 1, 2005; 115(2): 435 - 442. [Abstract] [Full Text] [PDF]

				W. Landier, S. Bhatia, D. A. Eshelman, K. J. Forte, T. Sweeney, A. L. Hester, J. Darling, F. D. Armstrong, J. Blatt, L. S. Constine, et al. Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline J. Clin. Oncol., December 15, 2004; 22(24): 4979 - 4990. [Abstract] [Full Text] [PDF]

				M. M. Hudson, A. C. Mertens, Y. Yasui, W. Hobbie, H. Chen, J. G. Gurney, M. Yeazel, C. J. Recklitis, N. Marina, L. R. Robison, et al. Health Status of Adult Long-term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study JAMA, September 24, 2003; 290(12): 1583 - 1592. [Abstract] [Full Text] [PDF]

				C.-H. Pui, C. Cheng, W. Leung, S. N. Rai, G. K. Rivera, J. T. Sandlund, R. C. Ribeiro, M. V. Relling, L. E. Kun, W. E. Evans, et al. Extended Follow-up of Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia N. Engl. J. Med., August 14, 2003; 349(7): 640 - 649. [Abstract] [Full Text] [PDF]

				M. Clarke, P. Gaynon, I. Hann, G. Harrison, G. Masera, R. Peto, and S. Richards CNS-Directed Therapy for Childhood Acute Lymphoblastic Leukemia: Childhood ALL Collaborative Group Overview of 43 Randomized Trials J. Clin. Oncol., May 1, 2003; 21(9): 1798 - 1809. [Abstract] [Full Text] [PDF]

				N. S. Kadan-Lottick, L. L. Robison, J. G. Gurney, J. P. Neglia, Y. Yasui, R. Hayashi, M. Hudson, M. Greenberg, and A. C. Mertens Childhood Cancer Survivors' Knowledge About Their Past Diagnosis and Treatment: Childhood Cancer Survivor Study JAMA, April 10, 2002; 287(14): 1832 - 1839. [Abstract] [Full Text] [PDF]

				A. C. Mertens, Y. Yasui, J. P. Neglia, J. D. Potter, M. E. Nesbit Jr, K. Ruccione, W. Anthony Smithson, and L. L. Robison Late Mortality Experience in Five-Year Survivors of Childhood and Adolescent Cancer: The Childhood Cancer Survivor Study J. Clin. Oncol., July 1, 2001; 19(13): 3163 - 3172. [Abstract] [Full Text] [PDF]

				T. R. Moller, S. Garwicz, L. Barlow, J. F. Winther, E. Glattre, G. Olafsdottir, J. H. Olsen, R. Perfekt, A. Ritvanen, R. Sankila, et al. Decreasing Late Mortality Among Five-Year Survivors of Cancer in Childhood and Adolescence: A Population-Based Study in the Nordic Countries J. Clin. Oncol., July 1, 2001; 19(13): 3173 - 3181. [Abstract] [Full Text] [PDF]

				V. L. Tyc, W. Hadley, and G. Crockett Predictors of Intentions to Use Tobacco Among Adolescent Survivors of Cancer J. Pediatr. Psychol., March 1, 2001; 26(2): 117 - 121. [Abstract] [Full Text] [PDF]

				W. Leung, M. M. Hudson, D. K. Strickland, S. Phipps, D. K. Srivastava, R. C. Ribeiro, J. E. Rubnitz, J. T. Sandlund, L. E. Kun, L. C. Bowman, et al. Late Effects of Treatment in Survivors of Childhood Acute Myeloid Leukemia J. Clin. Oncol., September 18, 2000; 18(18): 3273 - 3279. [Abstract] [Full Text] [PDF]

				G. Socie, R. E. Curtis, H. J. Deeg, K. A. Sobocinski, A. H. Filipovich, L. B. Travis, K. M. Sullivan, P. A. Rowlings, D. W. Kingma, P. M. Banks, et al. New Malignant Diseases After Allogeneic Marrow Transplantation for Childhood Acute Leukemia J. Clin. Oncol., January 14, 2000; 18(2): 348 - 348. [Abstract] [Full Text] [PDF]

				D. M. Green, A. Hyland, C. S. Chung, M. A. Zevon, and B. C. Hall Cancer and Cardiac Mortality Among 15-Year Survivors of Cancer Diagnosed During Childhood or Adolescence J. Clin. Oncol., October 1, 1999; 17(10): 3207 - 3215. [Abstract] [Full Text] [PDF]

				G. Socie, J. V. Stone, J. R. Wingard, D. Weisdorf, P. J. Henslee-Downey, C. Bredeson, J.-Y. Cahn, J. R. Passweg, P. A. Rowlings, H. C. Schouten, et al. Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation N. Engl. J. Med., July 1, 1999; 341(1): 14 - 21. [Abstract] [Full Text] [PDF]

				K. E. Nichols, S. Levitz, K. E. Shannon, D. C.R. Wahrer, D. W. Bell, G. Chang, S. Hegde, D. Neuberg, T. Shafman, N. J. Tarbell, et al. Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease J. Clin. Oncol., April 1, 1999; 17(4): 1259 - 1259. [Abstract] [Full Text] [PDF]